(News Bulletin 247) – UBS reiterates its advice to buy on the stock with a target of 380 E after a financial year 22 which the analyst considers ‘reassuring’.

“The annual results are reassuring on the underlying organic trends (UBSe c10.5% in 2023) and the prospects for reducing the costs of services (the impact of the announced exits is negligible)” indicates UBS.

Teleperformance reported a 15.8% increase in net income, group share, to €645 million, showing diluted net income per share of €10.8, compared to €9.36 a year earlier (i.e. increase of 15.4%) in twelve months.

The management also confirmed the 2025 financial objectives, i.e. at least 10 billion euros in turnover excluding acquisitions.

Copyright (c) 2023 News Bulletin 247. All rights reserved.